$CRVO
CervoMed Inc.

2014 Q2 Form 10-Q Financial Statement

#000110465914061096 Filed on August 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q4 2013 Q2
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $1.210M $290.0K $3.080M
YoY Change -60.71% -86.88% 23.2%
% of Gross Profit
Research & Development $266.9K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $323.7K $660.0K $7.481K
YoY Change 4227.51% -25.19%
% of Gross Profit
Operating Expenses $1.801M $940.0K $8.097M
YoY Change -77.75% -59.83% 223.88%
Operating Profit -$1.801M -$940.0K -$8.097M
YoY Change -77.75% -59.83% 233.21%
Interest Expense $136.6K $150.0K $35.08K
YoY Change 289.31% -97.81% -100.2%
% of Operating Profit
Other Income/Expense, Net -$2.840M $20.00K $10.57M
YoY Change -126.86% -99.84% -1491.28%
Pretax Income -$4.642M -$780.0K $2.480M
YoY Change -287.17% -104.89% -111.71%
Income Tax -$186.5K $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$4.455M -$810.0K $2.347M
YoY Change -289.79% -105.09% -111.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$49.56M -$40.50M $117.5M
COMMON SHARES
Basic Shares Outstanding 12.87M
Diluted Shares Outstanding 12.87M 2.862M shares

Balance Sheet

Concept 2014 Q2 2013 Q4 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.14M $250.0K $80.00K
YoY Change 33825.0% -19.35% 100.0%
Cash & Equivalents $27.14M $255.0K $78.60K
Short-Term Investments
Other Short-Term Assets $2.300M $2.740M $30.00K
YoY Change 7566.67% 3325.0% -78.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $29.44M $2.998M $170.0K
YoY Change 17216.6% 551.8% -32.0%
LONG-TERM ASSETS
Property, Plant & Equipment $56.26K $11.26K $30.00K
YoY Change 87.54% -77.48% -70.0%
Goodwill $11.24M $7.643M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $25.09M $15.35M $27.00K
YoY Change 92829.8% 671.14% -99.22%
TOTAL ASSETS
Total Short-Term Assets $29.44M $2.998M $170.0K
Total Long-Term Assets $25.09M $15.35M $27.00K
Total Assets $54.53M $18.34M $197.0K
YoY Change 27579.83% 648.74% -94.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $252.1K $1.520M $1.350M
YoY Change -81.32% 26.68% 28.57%
Accrued Expenses $1.690M $3.480M $3.870M
YoY Change -56.33% -7.94% -12.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $60.00K
YoY Change -100.0%
Long-Term Debt Due $920.0K $1.870M $2.080M
YoY Change -55.77% -53.25% -24.36%
Total Short-Term Liabilities $4.131M $8.878M $8.770M
YoY Change -52.89% -57.42% -0.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.131M $8.878M $8.770M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $9.232M $11.88M $8.767M
YoY Change 5.3% -42.97% -0.15%
SHAREHOLDERS EQUITY
Retained Earnings -$66.77M -$60.94M
YoY Change
Common Stock $112.1M $67.40M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $45.30M $6.459M -$8.540M
YoY Change
Total Liabilities & Shareholders Equity $54.53M $18.34M $200.0K
YoY Change 27164.63% 648.74% -94.61%

Cashflow Statement

Concept 2014 Q2 2013 Q4 2013 Q2
OPERATING ACTIVITIES
Net Income -$4.455M -$810.0K $2.347M
YoY Change -289.79% -105.09% -111.09%
Depreciation, Depletion And Amortization $323.7K $660.0K $7.481K
YoY Change 4227.51% -25.19%
Cash From Operating Activities -$4.690M $0.00 -$450.0K
YoY Change 942.22% -100.0% 12.5%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.61M 0.000 420.0K
YoY Change 7426.19% -100.0% -4.55%
NET CHANGE
Cash From Operating Activities -4.690M 0.000 -450.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 31.61M 0.000 420.0K
Net Change In Cash 26.92M 0.000 -30.00K
YoY Change -89833.33% -100.0% -175.0%
FREE CASH FLOW
Cash From Operating Activities -$4.690M $0.00 -$450.0K
Capital Expenditures $0.00
Free Cash Flow -$4.690M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1138715 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1935621 USD
resx Warrant Expense And Fair Value Charge For Stock Sales
WarrantExpenseAndFairValueChargeForStockSales
3595700 USD
resx Fair Value Of Common Stock Exchanged For Warrants
FairValueOfCommonStockExchangedForWarrants
3069792 USD
us-gaap Professional Fees
ProfessionalFees
433706 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
254964 USD
CY2013Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
2998283 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
29438222 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11262 USD
us-gaap Interest Expense
InterestExpense
194878 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52352 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
43697 USD
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4455232 USD
CY2014Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
12867845 shares
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12867845 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
9483395 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9483395 shares
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
111615 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5121098 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32005727 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26884629 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2476647 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
126778 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
2347490 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.87
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.07
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.05
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
-0.14
CY2014Q2 resx Contractual Obligation Due In Third Year And Beyond
ContractualObligationDueInThirdYearAndBeyond
USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1088619 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5879104 USD
us-gaap Operating Expenses
OperatingExpenses
5879104 USD
us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
10390000 USD
dei Entity Registrant Name
EntityRegistrantName
RestorGenex Corp
CY2014Q2 resx Due To Related Party Other Than Officer Current
DueToRelatedPartyOtherThanOfficerCurrent
150000 USD
CY2013Q4 us-gaap Goodwill
Goodwill
7642825 USD
CY2013Q4 us-gaap Assets
Assets
18344052 USD
CY2014Q2 us-gaap Assets
Assets
54529269 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001053691
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
7209585 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4131240 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1520206 USD
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5813785 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5813785 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18391193 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18391193 shares
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
261632 USD
CY2013Q2 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
1935621 USD
CY2014Q2 resx Rent Liability For Facilities No Longer Occupied
RentLiabilityForFacilitiesNoLongerOccupied
1121495 USD
CY2013Q2 resx Warrant Expense And Fair Value Charge For Stock Sales
WarrantExpenseAndFairValueChargeForStockSales
2279552 USD
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
89472 USD
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1697714 USD
CY2013Q4 resx Rent Liability For Facilities No Longer Occupied
RentLiabilityForFacilitiesNoLongerOccupied
1121495 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1667002 USD
CY2013Q4 resx Obligation To Issue Stock For Transfer Of Liabilities
ObligationToIssueStockForTransferOfLiabilities
1854743 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8878318 USD
CY2013Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
3000576 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
5814 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
67390493 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-60937550 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
6458757 USD
CY2013Q4 us-gaap Minority Interest
MinorityInterest
6401 USD
us-gaap Profit Loss
ProfitLoss
-129290 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6465158 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18344052 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
45297259 USD
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
45297259 USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54529269 USD
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
252141 USD
CY2014Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
592609 USD
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2013Q2 us-gaap Professional Fees
ProfessionalFees
290603 USD
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7481 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
8097090 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10573737 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
8980077 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1409530 USD
CY2013Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1409530 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17636 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8097090 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
35084 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16168 USD
us-gaap Operating Expenses
OperatingExpenses
10189702 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-10189702 USD
CY2013Q2 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
9216927 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-15072 USD
us-gaap Interest Expense
InterestExpense
58055 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10316480 USD
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1860 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56263 USD
us-gaap Depreciation
Depreciation
2555 USD
CY2014Q2 us-gaap Depreciation
Depreciation
395 USD
CY2013Q2 us-gaap Depreciation
Depreciation
7946 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4455232 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5835407 USD
CY2013Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
47250 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
171625 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2300240 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-300915 USD
CY2014Q2 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.35
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5835407 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.82
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2013Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2862264 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2862264 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1885485 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1885485 shares
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
514041 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.62
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
1935621 USD
resx Note Issued For Services
NoteIssuedForServices
50000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
49349 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-850994 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
417500 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
617500 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-233494 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27139593 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78599 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
312093 USD
CY2014Q2 resx Warrant Expense And Fair Value Charge For Stock Sales
WarrantExpenseAndFairValueChargeForStockSales
141315 USD
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
890837 shares
us-gaap Depreciation
Depreciation
17098 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
212816 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Use of Estimates</font></i></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of the Company&#8217;s consolidated financial statements in accordance with U.S.&#160;GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes.&#160; Although these estimates are based on the Company&#8217;s knowledge of current events and actions that the Company may undertake in the future, actual results may differ from such estimates and assumptions.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> </div>
resx Derivatives Fair Value Assumptions Schedule
DerivativesFairValueAssumptionsSchedule
<div style="font-size:10.0pt;font-family:Times New Roman;FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;"> <table style="text-align:left;TEXT-ALIGN: left; WIDTH: 987px; BORDER-COLLAPSE: collapse; MARGIN-LEFT: 0.6in;" border="0" cellspacing="0" cellpadding="0" width="987"> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 82.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="82%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Estimated fair value of underlying common stock</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.32%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12.42%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.00</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 82.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="82%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Remaining life in years</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">3.15</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 82.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="82%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Risk-free interest rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">0.38</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 82.28%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="top" width="82%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Expected volatility</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.86%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.74%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">142</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in;" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">%</font></p></td></tr> <tr style="padding:0;PADDING-BOTTOM: 0px; PADDING-LEFT: 0px; PADDING-RIGHT: 0px; PADDING-TOP: 0px;"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 82.28%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="top" width="82%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Dividend yield</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.86%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 13.74%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="13%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt;" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in;" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt;">&#160;</p></td></tr></table></div>
us-gaap Reclassifications
Reclassifications
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Reclassification</font></i></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Certain prior period amounts were reclassified to conform to the manner of presentation in the current period.&#160; These reclassifications had no effect on the net (loss) or the stockholders&#8217; equity.</font></p> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt;" align="center">&#160;</p> </div>
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58123 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
53563707 USD
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
50318257 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
47728300 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
44482850 USD
resx Market Capitalization
MarketCapitalization
74900000 USD
CY2013 resx Goodwill1
Goodwill1
15334507 USD
resx Goodwill1
Goodwill1
25034784 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
224078 USD
CY2014Q2 us-gaap Goodwill
Goodwill
11241987 USD
CY2013Q4 resx Unpaid Salaries Fees And Other Compensation
UnpaidSalariesFeesAndOtherCompensation
571328 USD
CY2013Q4 resx Payroll Related
PayrollRelated
479087 USD
CY2013Q4 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
393592 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
110000 USD
CY2013Q4 resx Accrued Board Fees
AccruedBoardFees
657934 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
57101 USD
CY2014Q2 resx Payroll Related
PayrollRelated
183021 USD
CY2014Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
393592 USD
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
287265 USD
CY2014Q2 resx Accrued Board Fees
AccruedBoardFees
210625 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
25492 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1099995 USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
71667 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
1667002 USD
CY2014Q2 us-gaap Notes Payable
NotesPayable
715000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
194878 USD
CY2014Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
136584 USD
CY2013Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
35084 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
58055 USD
CY2014Q2 us-gaap Contractual Obligation
ContractualObligation
6797743 USD
CY2013 resx Conversion Of Series E Preferred To Common Stock
ConversionOfSeriesEPreferredToCommonStock
1575000 shares
CY2013 resx Shares Issued For Acquisition Of Canterbury And Hygeia
SharesIssuedForAcquisitionOfCanterburyAndHygeia
1150116 shares
CY2013 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
576331 shares
CY2013 resx Issuance Of Shares For Advisory Agreements
IssuanceOfSharesForAdvisoryAgreements
243250 shares
CY2013 resx Issuance Of Shares To Third Party For Assumption Of Liabilities
IssuanceOfSharesToThirdPartyForAssumptionOfLiabilities
200000 shares
CY2013 us-gaap Stock Issued During Period Shares Issued For Cash
StockIssuedDuringPeriodSharesIssuedForCash
142501 shares
CY2013 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
12486 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
890837 shares
resx Shares Issued For Acquisition Of Vasculomedics
SharesIssuedForAcquisitionOfVasculomedics
220000 shares
resx Shares Issued For Acquisition Of Paloma
SharesIssuedForAcquisitionOfPaloma
2500000 shares
resx Issuance Of Shares To Third Party For Assumption Of Liabilities
IssuanceOfSharesToThirdPartyForAssumptionOfLiabilities
150000 shares
CY2013Q2 us-gaap Liabilities
Liabilities
8767000 USD
CY2013Q2 us-gaap Assets
Assets
197000 USD
CY2014Q2 us-gaap Notes Payable Current
NotesPayableCurrent
715000 USD
CY2014Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent
5100770 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
18391 USD
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
112051825 USD
CY2013Q2 resx Fair Value Of Common Stock Exchanged For Warrants
FairValueOfCommonStockExchangedForWarrants
3069792 USD
CY2013 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66772957 USD
CY2014Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
62000 USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
-62000 USD
CY2014Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable
DisposalGroupIncludingDiscontinuedOperationAccountsPayable
167244 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Accrued Liabilities
DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities
16250 USD
CY2013Q4 us-gaap Disposal Group Including Discontinued Operation Other Liabilities
DisposalGroupIncludingDiscontinuedOperationOtherLiabilities
-183494 USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
USD
CY2014Q2 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
USD
CY2014Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
USD
CY2014Q2 resx Disposal Group Including Discontinued Operation Expenses
DisposalGroupIncludingDiscontinuedOperationExpenses
USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
USD
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
USD
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
USD
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
USD
resx Market Capitalization As Percentage Of Goodwill And Intangible Assets
MarketCapitalizationAsPercentageOfGoodwillAndIntangibleAssets
0.33 pure
resx Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00 pure
CY2013 resx Deferred Tax Assets Valuation Allowance Percentage
DeferredTaxAssetsValuationAllowancePercentage
1.00 pure
resx Value Of Shares Of Common Stock Recognized Per Quarter
ValueOfSharesOfCommonStockRecognizedPerQuarter
262813 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
238575 USD
us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
USD
resx Disposal Group Including Discontinued Operation Expenses
DisposalGroupIncludingDiscontinuedOperationExpenses
USD
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
USD
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
USD
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
110744 USD
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
26165 USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7752 USD
CY2013Q2 resx Disposal Group Including Discontinued Operation Expenses
DisposalGroupIncludingDiscontinuedOperationExpenses
129157 USD
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
71667 USD
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
284111 USD
us-gaap Disposal Group Including Discontinued Operation Interest Expense
DisposalGroupIncludingDiscontinuedOperationInterestExpense
58055 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-14431 USD
resx Disposal Group Including Discontinued Operation Expenses
DisposalGroupIncludingDiscontinuedOperationExpenses
327735 USD
resx Working Capital And Other Adjustments Discontinue Operations
WorkingCapitalAndOtherAdjustmentsDiscontinueOperations
39543 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-216525 USD
us-gaap Net Cash Provided By Used In Discontinued Operations
NetCashProvidedByUsedInDiscontinuedOperations
-216525 USD
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-4455232 USD
CY2014Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
100 pure
CY2013Q3 resx Value Of Liabilities To Be Acquired By Financial Firm As Per Agreement With Creditors
ValueOfLiabilitiesToBeAcquiredByFinancialFirmAsPerAgreementWithCreditors
1865386 USD
CY2013Q4 resx Number Of Shares Issued To Financial Firm
NumberOfSharesIssuedToFinancialFirm
200000 shares
CY2014Q1 resx Number Of Shares Issued To Financial Firm
NumberOfSharesIssuedToFinancialFirm
150000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
31605727 USD
CY2014Q2 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
3380972 USD
CY2014Q2 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
1877972 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.62
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
571328 USD
CY2014Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-4455232 USD
CY2013 resx Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
1023264 shares
us-gaap Profit Loss
ProfitLoss
-5835407 USD
CY2014Q2 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1538799 USD
CY2013Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
USD
CY2013Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
USD
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
USD
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
USD
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18468125 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-129157 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
873477 USD
resx Warrant Expense And Fair Value Charge For Stock Sales
WarrantExpenseAndFairValueChargeForStockSales
291200 USD
CY2014Q2 resx Fair Value Of Common Stock Exchanged For Warrants
FairValueOfCommonStockExchangedForWarrants
2706105 USD
CY2014Q2 us-gaap Professional Fees
ProfessionalFees
384604 USD
us-gaap Professional Fees
ProfessionalFees
516290 USD
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
610515 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
4507584 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4507584 USD
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
188936 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
136584 USD
CY2014Q2 resx Prepaid Expenses Deposits And Other Assets
PrepaidExpensesDepositsAndOtherAssets
2298629 USD
CY2013Q4 resx Prepaid Expenses Deposits And Other Assets
PrepaidExpensesDepositsAndOtherAssets
2743319 USD
CY2014Q2 us-gaap Liabilities
Liabilities
9232010 USD
CY2013Q4 us-gaap Liabilities
Liabilities
11878894 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
403413 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
403413 USD
CY2014Q2 resx Fair Value Of Common Stock Exchanged For Warrants And Notes Payable
FairValueOfCommonStockExchangedForWarrantsAndNotesPayable
2706105 USD
CY2013Q2 resx Fair Value Of Common Stock Exchanged For Warrants And Notes Payable
FairValueOfCommonStockExchangedForWarrantsAndNotesPayable
3069792 USD
resx Fair Value Of Common Stock Exchanged For Warrants And Notes Payable
FairValueOfCommonStockExchangedForWarrantsAndNotesPayable
2706105 USD
resx Fair Value Of Common Stock Exchanged For Warrants And Notes Payable
FairValueOfCommonStockExchangedForWarrantsAndNotesPayable
3069792 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6056 USD
resx Gains Losses On Extinguishment Of Related Party Debt
GainsLossesOnExtinguishmentOfRelatedPartyDebt
-1829561 USD
resx Gain Loss On Settlement Of Shares Issued For Liabilities
GainLossOnSettlementOfSharesIssuedForLiabilities
-1285493 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3436876 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1209083 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
400000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
resx Fair Value Of Stock Issued To Related Party For Conversion Of Note Payable And Accrued Interest
FairValueOfStockIssuedToRelatedPartyForConversionOfNotePayableAndAccruedInterest
1105475 USD
resx Fair Value Of Stock Issued For Settlement Of Accrued Liabilities Accounts Payable And Notes Payable
FairValueOfStockIssuedForSettlementOfAccruedLiabilitiesAccountsPayableAndNotesPayable
1879349 USD
CY2014Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-6056 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
156358 USD
CY2014Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
150000 USD
resx Stock Issued During Period Shares Issued In Private Placement
StockIssuedDuringPeriodSharesIssuedInPrivatePlacement
8845685 shares
resx Stock Issued During Period Shares Issued To Creditors In Connection With Settlement Of Debt
StockIssuedDuringPeriodSharesIssuedToCreditorsInConnectionWithSettlementOfDebt
408317 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
552738 shares
resx Common Stock Shares Surrendered Pursuant To Amendment Of Settlement Agreement And Stipulation
CommonStockSharesSurrenderedPursuantToAmendmentOfSettlementAgreementAndStipulation
99332 shares
us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
12676740 shares
resx Shares Issued For Acquisition Of Paloma And Vasculo Medics
SharesIssuedForAcquisitionOfPalomaAndVasculoMedics
2720000 shares
resx Stock Issued During Period Shares Issued To Creditors In Connection With Settlement Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToCreditorsInConnectionWithSettlementOfOutstandingDebt
408317 shares
resx Stock Issued During Period Aggregate Shares Issued In Private Placement
StockIssuedDuringPeriodAggregateSharesIssuedInPrivatePlacement
8845685 shares
CY2014Q2 resx Stock Issued During Period Shares Issued To Institutional And Accredited Investors
StockIssuedDuringPeriodSharesIssuedToInstitutionalAndAccreditedInvestors
2776500 shares
CY2014Q2 resx Class Of Warrant Or Right Term Of Warrants Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightTermOfWarrantsIssuedToInstitutionalAndAccreditedInvestors
P4Y
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
832950 shares
CY2014Q2 resx Number Of Shares Of Common Stock Consisted In Unit
NumberOfSharesOfCommonStockConsistedInUnit
1 shares
resx Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-0.23
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Placement Agent
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToPlacementAgent
87231 shares
resx Class Of Warrant Or Right Term Of Warrants Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightTermOfWarrantsIssuedToInstitutionalAndAccreditedInvestors
P4Y
CY2014Q2 resx Number Of Warrants Consisted In Unit
NumberOfWarrantsConsistedInUnit
0.3 shares
CY2014Q2 us-gaap Share Price
SharePrice
4.00
CY2014Q2 resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
4.80
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Placement Agent
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToPlacementAgent
277650 shares
CY2014Q2 resx Stock Issued During Period Shares Issued To Institutional And Accredited Investors
StockIssuedDuringPeriodSharesIssuedToInstitutionalAndAccreditedInvestors
3418125 shares
CY2014Q2 resx Class Of Warrant Or Right Term Of Warrants Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightTermOfWarrantsIssuedToInstitutionalAndAccreditedInvestors
P4Y
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
1025438 shares
CY2014Q2 resx Number Of Shares Of Common Stock Consisted In Unit
NumberOfSharesOfCommonStockConsistedInUnit
1 shares
CY2014Q2 resx Number Of Warrants Consisted In Unit
NumberOfWarrantsConsistedInUnit
0.3 shares
CY2014Q2 us-gaap Share Price
SharePrice
4.00
CY2014Q2 resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
4.80
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Placement Agent
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToPlacementAgent
341813 shares
CY2014Q2 resx Stock Issued During Period Shares Issued To Institutional And Accredited Investors
StockIssuedDuringPeriodSharesIssuedToInstitutionalAndAccreditedInvestors
872310 shares
CY2014Q2 resx Class Of Warrant Or Right Term Of Warrants Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightTermOfWarrantsIssuedToInstitutionalAndAccreditedInvestors
P4Y
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
254193 shares
CY2014Q2 resx Number Of Shares Of Common Stock Consisted In Unit
NumberOfSharesOfCommonStockConsistedInUnit
1 shares
CY2014Q2 resx Number Of Warrants Consisted In Unit
NumberOfWarrantsConsistedInUnit
0.3 shares
CY2014Q2 us-gaap Share Price
SharePrice
4.00
CY2014Q2 resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
4.80
CY2014Q2 resx Stock Issued During Period Shares Issued To Institutional And Accredited Investors
StockIssuedDuringPeriodSharesIssuedToInstitutionalAndAccreditedInvestors
1778750 shares
CY2014Q2 resx Class Of Warrant Or Right Term Of Warrants Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightTermOfWarrantsIssuedToInstitutionalAndAccreditedInvestors
P4Y
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
533625 shares
CY2014Q2 resx Number Of Shares Of Common Stock Consisted In Unit
NumberOfSharesOfCommonStockConsistedInUnit
1 shares
CY2014Q2 resx Number Of Warrants Consisted In Unit
NumberOfWarrantsConsistedInUnit
0.3 shares
CY2014Q2 us-gaap Share Price
SharePrice
4.00
CY2014Q2 resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
4.80
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Placement Agent
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToPlacementAgent
177875 shares
resx Stock Issued During Period Shares Issued To Institutional And Accredited Investors
StockIssuedDuringPeriodSharesIssuedToInstitutionalAndAccreditedInvestors
50000 shares
resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
15000 shares
resx Number Of Shares Of Common Stock Consisted In Unit
NumberOfSharesOfCommonStockConsistedInUnit
1 shares
resx Number Of Warrants Consisted In Unit
NumberOfWarrantsConsistedInUnit
0.3 shares
CY2014Q3 us-gaap Share Price
SharePrice
4.00
resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Institutional And Accredited Investors
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToInstitutionalAndAccreditedInvestors
4.80
resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Placement Agent
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToPlacementAgent
5000 shares
resx Net Proceeds From Issuance Of Private Placement
NetProceedsFromIssuanceOfPrivatePlacement
31300000 USD
CY2014Q3 resx Number Of Shares Of Common Stock For Which Registration Statement Is Filed For Offering And Resale Of Common Stock
NumberOfSharesOfCommonStockForWhichRegistrationStatementIsFiledForOfferingAndResaleOfCommonStock
11633885 shares
CY2014Q2 resx Stock Issued During Period Shares Issued To Creditors In Connection With Conversion Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToCreditorsInConnectionWithConversionOfOutstandingDebt
259236 shares
CY2014Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
500000 USD
CY2014Q2 resx Stock Issued During Period Shares Issued To Creditors In Connection With Settlement Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToCreditorsInConnectionWithSettlementOfOutstandingDebt
164392 shares
CY2014Q2 resx Number Of Creditors To Whom Shares Are Issued In Connection With Settlement Of Outstanding Debt
NumberOfCreditorsToWhomSharesAreIssuedInConnectionWithSettlementOfOutstandingDebt
4 item
CY2014Q2 resx Stock Issued During Period Shares Issued To Former Chief Financial Officer In Connection With Settlement Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToFormerChiefFinancialOfficerInConnectionWithSettlementOfOutstandingDebt
59250 shares
CY2014Q2 resx Stock Issued During Period Shares Issued To Chairman In Connection With Settlement Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToChairmanInConnectionWithSettlementOfOutstandingDebt
552738 shares
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Chairman In Connection With Settlement Of Outstanding Debt
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToChairmanInConnectionWithSettlementOfOutstandingDebt
355699 shares
CY2014Q2 resx Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued To Chairman
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssuedToChairman
2.00
CY2014Q2 resx Number Of Debt Instruments Issued
NumberOfDebtInstrumentsIssued
4 item
CY2014Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
1050000 USD
CY2014Q2 resx Stock Issued During Period Shares Issued To Law Firm In Connection With Conversion Of Outstanding Debt
StockIssuedDuringPeriodSharesIssuedToLawFirmInConnectionWithConversionOfOutstandingDebt
53457 shares
CY2014Q2 resx Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Issued To Law Firm
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsIssuedToLawFirm
16037 shares
CY2013Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
1676602 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-6073817 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1322096 USD
CY2014Q2 resx Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-0.44
CY2013Q2 resx Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
0.25
resx Business Acquisition Pro Forma Earnings Per Share Basic And Diluted
BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted
-1.45
resx Profit After Cost Of Sales And Depreciation
ProfitAfterCostOfSalesAndDepreciation
-1089000 USD
CY2013Q2 resx Profit After Cost Of Sales And Depreciation
ProfitAfterCostOfSalesAndDepreciation
-7000 USD
resx Profit After Cost Of Sales And Depreciation
ProfitAfterCostOfSalesAndDepreciation
-17000 USD
CY2014Q2 resx Profit After Cost Of Sales And Depreciation
ProfitAfterCostOfSalesAndDepreciation
-610000 USD
resx Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
4790000 USD
CY2013Q2 resx Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
8090000 USD
resx Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
10139000 USD
CY2014Q2 resx Operating Expenses Excluding Depreciation
OperatingExpensesExcludingDepreciation
3897000 USD
CY2013Q2 us-gaap Gain On Derivative Instruments Pretax
GainOnDerivativeInstrumentsPretax
9217000 USD
resx Depreciation Depletion And Amortization Including Discontinued Operations
DepreciationDepletionAndAmortizationIncludingDiscontinuedOperations
1088619 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
1284744 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
1284744 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
1284744 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
1284744 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
1284744 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
35600000 USD
resx Payments Of Placement Agent Fees In Private Placement
PaymentsOfPlacementAgentFeesInPrivatePlacement
3600000 USD
resx Payments Of Estimated Offering Expenses In Private Placement
PaymentsOfEstimatedOfferingExpensesInPrivatePlacement
200000 USD
resx Payments Of Accounts Payable In Private Placement
PaymentsOfAccountsPayableInPrivatePlacement
500000 USD
CY2014Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
32608 USD
CY2014Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1829561 USD
CY2013Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
156358 USD
CY2014Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200000 USD
CY2013Q4 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 item
CY2014Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 item
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-238129 USD
CY2013 resx Market Capitalization
MarketCapitalization
17400000 USD
CY2013 resx Market Capitalization As Percentage Of Goodwill And Intangible Assets
MarketCapitalizationAsPercentageOfGoodwillAndIntangibleAssets
1.13 pure
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-256068 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
14388120 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7779000 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
595323 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
87318 USD
CY2014Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13792797 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7691682 USD
resx Depreciation Depletion And Amortization Including Discontinued Operations
DepreciationDepletionAndAmortizationIncludingDiscontinuedOperations
17098 USD
resx Warrant Expense And Fair Value Charge For Stock Sales Including Discontinued Operations
WarrantExpenseAndFairValueChargeForStockSalesIncludingDiscontinuedOperations
291200 USD
resx Warrant Expense And Fair Value Charge For Stock Sales Including Discontinued Operations
WarrantExpenseAndFairValueChargeForStockSalesIncludingDiscontinuedOperations
3607283 USD

Files In Submission

Name View Source Status
0001104659-14-061096-index-headers.html Edgar Link pending
0001104659-14-061096-index.html Edgar Link pending
0001104659-14-061096.txt Edgar Link pending
0001104659-14-061096-xbrl.zip Edgar Link pending
a14-17441_110q.htm Edgar Link pending
a14-17441_1ex10d10.htm Edgar Link pending
a14-17441_1ex10d11.htm Edgar Link pending
a14-17441_1ex10d6.htm Edgar Link pending
a14-17441_1ex10d7.htm Edgar Link pending
a14-17441_1ex10d8.htm Edgar Link pending
a14-17441_1ex31d1.htm Edgar Link pending
a14-17441_1ex31d2.htm Edgar Link pending
a14-17441_1ex32d1.htm Edgar Link pending
a14-17441_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g174411kui001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
resx-20140630.xml Edgar Link completed
resx-20140630.xsd Edgar Link pending
resx-20140630_cal.xml Edgar Link unprocessable
resx-20140630_def.xml Edgar Link unprocessable
resx-20140630_lab.xml Edgar Link unprocessable
resx-20140630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending